Metamizole Safety In Spotlight As EMA Tackles Pregnancy/Lactation Labeling Disarray
Executive Summary
More than 50 metamizole-containing medicines are being reviewed by the European Medicines Agency because of substantial differences in their national product labeling regarding dosage and contraindications in pregnant and breastfeeding women.
You may also be interested in...
Two Orphans And An Avastin Biosimilar Among EU Approval Recommendations
Seven new drug applications got the thumbs up this week from the EMA's drug evaluation committee, the CHMP. Their EU approval should now be a formality. Two new Shionogi treatments are set for approval, as are two orphan products – one from Medac, the other from AOP Orphan Pharmaceuticals. Pfizer got the OK for one biosimilar but has withdrawn an application for another.
Spain Investigates Metamizole Risks In Expat Britons
Metamizole is in the safety spotlight again after the Spanish regulator said it was investigating reports of deaths and serious side-effects in expatriate and holidaymaking Britons caused by the painkiller.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.